DKFZ MRinRT 2021 – Virtual
18-21 April 2021
Germany
![](https://usercontent.one/wp/www.therapanacea.eu/wp-content/uploads/2021/05/NikosParagios.jpg?media=1695976153)
“The development of a fully adaptive, AI-powered treatment planning software is urgently needed. We are proud to be introducing our new era of MR-based proudcts that will pave the way towards this vision of radiation therapy on the fly for more efficient, safe and precise treatment for cancer patients.
CEO & CTO at TheraPanaceaProfessor of Mathematics – University of Paris-Saclay
Editor in Chief, Computer Vision at Elsevier
WEBINAR
AI: the missing link in MR-guided radiotherapy?
TheraPanacea is thrilled to engage a fascinating conversation with experts in Medical Physics, Radio-oncology and AI, come & listen to their insights.
![](https://usercontent.one/wp/www.therapanacea.eu/wp-content/uploads/2021/05/daniela.jpeg?media=1695976153)
Prof. Daniela Thorwarth
University Hospital Tübingen,
Germany
![](https://usercontent.one/wp/www.therapanacea.eu/wp-content/uploads/2021/05/enis-ozyar-petit-uai-200x200.png?media=1695976153)
Prof. Enis Özyar
Acibadem MAA University, Maslak Hospital,
Istanbul
![](https://usercontent.one/wp/www.therapanacea.eu/wp-content/uploads/2021/02/Nikolaos-PARAGYIOS.png?media=1695976153)
Prof. Nikos Paragyios
Founder & CEO
TheraPanacea
![](https://usercontent.one/wp/www.therapanacea.eu/wp-content/uploads/2021/02/Thais-ROQUE.png?media=1695976153)
Thais ROQUE, PhD
Research & Clinical Partnerships Manager
TheraPanacea
What do KOLs think of ART-Plan™?
“ART-Plan™ has experienced a very high level of acceptance in the different teams of our department in the University Hospital for Radiation Oncology Tübingen, Germany, as it saves a lot of valuable time that can be used for complex treatment planning tasks and interdisciplinary discussions.
![](https://usercontent.one/wp/www.therapanacea.eu/wp-content/uploads/2021/05/daniela.jpeg?media=1695976153)
Symposium
Get smarter – AI in Radiation Oncology